First-hand experiences of taking antipsychotics: findings from a large online survey

christina-victoria-craft-WHSnkIwWpec-unsplash

Georgie Buswell summarises a cross-sectional study, which used open questions to try and understand people’s lived experiences of taking antipsychotic drugs.

[read the full story...]

Psychological interventions effective for improving mental health and sleep following complex trauma

Featured

In her debut blog, Delia Ciobotaru explores a network meta-analysis which finds that psychological treatments are effective in reducing PTSD symptoms experienced by people with complex trauma.

[read the full story...]

Experience of psychotropic medication and decision-making

laurynas-mereckas-1TL8AoEDj_c-unsplash

Jennifer Rose Oulton reviews a qualitative study that explores the experiences of psychotropic medication use and decision-making for adults with learning disabilities and their carers.

[read the full story...]

Antipsychotics versus CBT in first episode psychosis: some answers, more questions

shutterstock_210297724

Joe Pierre summarises two recently published and widely reported RCTs, which suggest that antipsychotic medication might not offer an advantage over psychotherapy in broadly-defined first episode psychosis.

[read the full story...]

Sex and schizophrenia: what determines sexual interest and confidence?

kelly-sikkema-XX2WTbLr3r8-unsplash

In her debut blog, Beccy White summarises a secondary analysis which explored predictors of sexual interest amongst older adults with schizophrenia.

[read the full story...]

Antipsychotics for schizophrenia: do they provide a longer, healthier life?

michal-parzuchowski-7TWRwDjfGew-unsplash

Paul Heron from the Closing the Gap Network writes his debut blog about a 20‐year cohort study of physical morbidity and mortality in relationship to antipsychotic treatment in a huge group of people with schizophrenia in Finland.

[read the full story...]

Risperidone and aripiprazole: genotype, metabolism and dosage

CYP2D6 genotyping before starting treatment might be valuable in clinical practice for individualising risperidone and aripiprazole treatment.

Dolly Sud writes her debut elf blog on a recent retrospective analysis, which compares dose changes of risperidone and aripiprazole with patients’ individual genotype.

[read the full story...]

Antipsychotics and metabolic function in people with schizophrenia

Featured

Peter Haddad and Sami Ouanes review a network meta-analysis of the impact of antipsychotic drugs on metabolic function in people with schizophrenia.

[read the full story...]

The Trial: pharmacotherapy versus psychotherapy for schizophrenia – how do trials compare?

thetrial

Keith Laws looks at a systematic review of patient and study characteristics, which asks: are randomised controlled trials on pharmacotherapy and psychotherapy for positive symptoms of schizophrenia comparable?

[read the full story...]

Cognitive functioning in psychosis: is neuropsychological decline continuous, generalised, and specific to schizophrenia?

shutterstock_1466819675

Emmeline Lagunes Cordoba and Derek Tracy explore a case control study that looks at cognitive change in people with schizophrenia and other psychoses in the decade following the first episode.

[read the full story...]